FDA Inspection 1248457 — Octapharma Plasma Inc
The FDA completed an inspection of Octapharma Plasma Inc on Aug 22, 2024 in Montgomery, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 22, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Montgomery, AL (United States)